Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Change in the "Drug Production License" of Zhongyi Pharmaceuticals

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its wholly-owned subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Zhongyi Pharmaceutical Co., Ltd. ("Zhongyi Pharmaceutical"), has recently received the "Drug Production License" approved and issued by the Guangdong Provincial Drug Administration, allowing Zhongyi Pharmaceutical to decrease production lines and add new production lines. The reduction and addition of production lines by Zhongyi Pharmaceutical this time will help the company optimize resource allocation, continue to maintain stable production capacity, and meet market demand.